We are pleased to announce the newest members of the EMGS Council, Executive Board, and Endowment Fund Board. Each new member will serve a 3-year term in their respective positions.

Vice President-Elect
Jeff Bemis, Litron Laboratories
Position is effective immediately.

Council
Ryan Barnes, University of Kansas Medical Center
Xiaoqing Carole Guo, NCTR, US FDA 
Annie Hamel, Charles River Laboratories
Cheryl Hobbs, Inotiv
Shaofei Zhang, Pfizer
Councilors will fill their positions at the conclusion of the 2025 EMGS business meeting in Rochester, NY.

Endowment Fund Board Chair 
Bret D. Freudenthal, University of Kansas Medical Center
Position is effective immediately.

Congratulations and thank you to our new leadership – we appreciate your dedication and service to the EMGS! We also thank all the candidates who offered their names for consideration and look forward to everyone's engagement in the Society.